Healthcare (Medical Licensing)

HB 342 requires Alaska's State Medical Board to create a standardized informed consent form for minors receiving sex-reassignment treatments or procedures. The form must include specific disclaimers, such as that the FDA hasn't approved puberty blockers or hormones for gender dysphoria, that other countries recommend psychotherapy first, and that these treatments carry risks like sterility, heart disease, and unknown brain development effects. It directly affects minors seeking gender-affirming care, their physicians, and the State Medical Board. The bill modifies medical licensing regulations to mandate this form before any such treatment, requiring it to be provided at every visit for at least one year. The bill is currently under review by the Health & Social Services committee.